Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b-Reference-Cited by-同舟云学术

Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b

Published:2023-04 Issue: Volume:860 Page:147230
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Wei Xinyu,Tao Shuang,Mao Huilan,Zhu Haitao,Mao Lingyu,Pei Wenhao,Shi Xiuru,Shi Yingxiang,Zhang Shiwen,Wu Yulun,Wei Ke,Wang Jing,Pang Siyan,Wang Wenrui,Chen Changjie,Yang Qingling

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference34 articles.

1. Paclitaxel's mechanistic and clinical effects on breast cancer;Abu Samaan;Biomolecules,2019

2. Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells;Agarwal;Cell Stem Cell,2019

3. Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation;Ahirwa;Oncogene,2018

4. Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma;Chiang;Neurotherapeutics,2022

5. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications;Corrado;Int. J. Mol. Sci.,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal lncRNAs as regulators of breast cancer chemoresistance and metastasis and their potential use as biomarkers;Frontiers in Oncology;2024-08-01

2. lncRNAs: New players of cancer drug resistance via targeting ABC transporters;IUBMB Life;2024-08

3. LncRNA NEAT1 promotes proliferation, migration, and invasion of laryngeal squamous cell carcinoma cells through miR-411-3p/FZD3-mediated Wnt signaling pathway;BMC Cancer;2024-07-27

4. The role of lncRNA NEAT1 in human cancer chemoresistance;Cancer Cell International;2024-07-05

5. Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA;Discover Oncology;2024-05-01